Filing Details

Accession Number:
0001455244-10-000109
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-11 13:00:00
Reporting Period:
2010-06-11
Filing Date:
2010-06-11
Accepted Time:
2010-06-11 17:20:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1278129 Osteologix Inc. OLGX OB Pharmaceutical Preparations (2834) 320104570
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360509 Florian Schonharting Ostergade 5, 3Rd Floor, Dk-1100
Copenhagen K G7
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2010-06-11 1,494,532 $0.50 6,517,264 No 4 P Indirect By Nordic Biotech Opportunity Fund K/S
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Nordic Biotech Opportunity Fund K/S
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share 15,133,061 Indirect By Nordic Biotech K/S
Common Stock, Par Value $0.0001 Per Share 20,000 Direct
Footnotes
  1. Mr. Sch?nharting is a principal of Nordic Biotech Opportunity Fund K/S, which is the record holder of 6,517,264 shares of Common Stock. Mr. Sch?nharting disclaims beneficial ownership of the securities held by Nordic Biotech Opportunity Fund K/S, except to the extent of his pecuniary interest therein.
  2. Mr. Sch?nharting is a principal of Nordic Biotech K/S, which is the record holder of 15,133,061 shares of Common Stock. Mr. Sch?nharting disclaims beneficial ownership of the securities held by Nordic Biotech K/S, except to the extent of his pecuniary interest therein.